These compounds may interact with:
Sodium-dependent dopamine transporter
Potentially involved in: alcohol dependence; neurodegenerative disease; parkinson's disease; dystonia; carcinoma; attention deficit hyperactivity disorder; toxic encephalopathy; substance abuse; schizophrenia; multiple system atrophy; brain disease; dementia; bipolar disorder; rem sleep behavior disorder; cocaine dependence; obsessive-compulsive disorder; gilles de la tourette syndrome; conduct disorder; nicotine dependence; pathological gambling
Disease data sourced from Pharos.